What is the Market's View on Esperion Therapeutics Inc (ESPR) Stock's Price and Volume Trends Thursday?

Overall market sentiment has been high on Esperion Therapeutics Inc (ESPR) stock lately. ESPR receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Esperion Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ESPR!

See Full ESPR Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ESPR Stock Today?

Esperion Therapeutics Inc (ESPR) stock is trading at $7.21 as of 3:27 PM on Thursday, Aug 18, a rise of $0.21, or 3% from the previous closing price of $7.00. The stock has traded between $6.69 and $7.27 so far today. Volume today is high. So far 1,465,260 shares have traded compared to average volume of 712,431 shares.

More About Esperion Therapeutics Inc

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Click Here to get the full Stock Report for Esperion Therapeutics Inc stock.